|
Sub-sample
|
Weight
|
BBV-TRAQ Score
|
F
|
p-value
|
mean difference (HCV positive & negative)
|
95% CI of the difference
|
|---|
|
Initiated injecting ≤ 3 years
|
None
|
Injecting subscale
|
3.93
|
.033
|
10.76
|
0.63 – 20.88
|
| | |
Total
|
2.65
|
.076
|
14.5
|
-1.05 – 30.05
|
| |
Log 1
|
Injecting subscale
|
4.48
|
.016
|
46.35
|
6.66 – 86.04
|
| | |
Total
|
4.19
|
.018
|
54.35
|
7.12 – 101.58
|
| |
Log 2
|
Injecting subscale
|
5.49
|
.005
|
120.02
|
28.99 – 211.04
|
| | |
Total
|
5.41
|
.006
|
130.32
|
31.25 – 229.39
|
| |
Log 5
|
Injecting subscale
|
7.11
|
.001
|
3,696
|
1,278 – 6,113
|
| | |
Total
|
7.19
|
.001
|
3,752
|
1,298 – 6,205
|
|
Aged ≤ 25 years
|
None
|
Injecting subscale
|
12.50
|
<.001
|
12.97
|
6.69 – 19.24
|
| | |
Total
|
8.97
|
<.001
|
17.15
|
7.36 – 26.93
|
| |
Log 1
|
Injecting subscale
|
13.66
|
<.001
|
53.88
|
28.95 – 78.82
|
| | |
Total
|
12.08
|
<.001
|
61.28
|
31.15 – 91.41
|
| |
Log 2
|
Injecting subscale
|
14.46
|
<.001
|
134.11
|
73.86 – 194.36
|
| | |
Total
|
13.70
|
<.001
|
143.11
|
77.05 – 209.16
|
| |
Log 5
|
Injecting subscale
|
14.16
|
<.001
|
3,915
|
2,132 – 5,698
|
| | |
Total
|
13.69
|
<.001
|
3,939
|
2,114 – 5,764
|
- * Comparisons were made between all HCV groups (i.e., inclusive of 'never tested/not sure' group). To simplify tables only results relevant to the focus of this paper have been presented (i.e., 'HCV positive' and 'HCV negative'). No differences were detected between the 'never tested/not sure' and other groups.
